These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Abbott's Norvir price hike is bad medicine. Statement at the NIH public meeting on Norvir. Huff B GMHC Treat Issues; 2004; 18(5-6):10-2. PubMed ID: 15359438 [No Abstract] [Full Text] [Related]
8. Drug pricing. AHF sues Abbott over drug price increase. AIDS Policy Law; 2004 Feb; 19(4):2. PubMed ID: 15045981 [No Abstract] [Full Text] [Related]
17. Effects of the ritonavir price increase on the cost of protease inhibitor regimens in United States. Lee WC; Williams KW; Chen E; Liu LZ; Pashos CL Manag Care Interface; 2006 Mar; 19(3):27-32. PubMed ID: 16583786 [TBL] [Abstract][Full Text] [Related]
18. Open letter from ATAC to Abbott's CEO, Miles White. Dee L; Sharp M GMHC Treat Issues; 2003 Dec; 17(12):5. PubMed ID: 15011642 [No Abstract] [Full Text] [Related]
19. Intellectual property. NIH weighs demand to force sharing of AIDS drug patents. Malakoff D Science; 2004 Jun; 304(5676):1427-9. PubMed ID: 15178775 [No Abstract] [Full Text] [Related]
20. Therapy. Direct purchasers may proceed with claims against Abbott. AIDS Policy Law; 2011 Mar; 26(4):5. PubMed ID: 21539034 [No Abstract] [Full Text] [Related] [Next] [New Search]